Wuxi AstraZeneca CICC Venture Capital Partnership Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Investments
  • 15

  • Portfolio
  • 13

  • Exits
  • 1

Exits

Wuxi AstraZeneca CICC Venture Capital Partnership General Information

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Growth/Expansion
Corporate Office
  • China

Wuxi AstraZeneca CICC Venture Capital Partnership Investments (15)

Wuxi AstraZeneca CICC Venture Capital Partnership’s most recent investment was a with Danatlas Pharmaceutical for . The deal was made on 03-Mar-2025.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Danatlas Pharmaceutical 03-Mar-2025 Drug Discovery Product Development
Cholesgen Pharmaceutical 18-Oct-2024 Drug Discovery Product Development
ETERN Therapeutics 01-Apr-2024 Drug Discovery Pre-Clinical Trials
Norchem Pharmaceutical 14-Oct-2023 Drug Discovery Profitable
Cholesgen Pharmaceutical 30-May-2023 Early Stage VC Drug Discovery Product Development
You’re viewing 5 of 15 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wuxi AstraZeneca CICC Venture Capital Partnership Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Wuxi AstraZeneca CICC Venture Capital Partnership FAQs

  • Where is Wuxi AstraZeneca CICC Venture Capital Partnership headquartered?

    Wuxi AstraZeneca CICC Venture Capital Partnership is headquartered in China.

  • How many investments has Wuxi AstraZeneca CICC Venture Capital Partnership made?

    Wuxi AstraZeneca CICC Venture Capital Partnership has made 15 investments.

  • What has Wuxi AstraZeneca CICC Venture Capital Partnership invested in?

    Wuxi AstraZeneca CICC Venture Capital Partnership has made numerous investments in companies like Danatlas Pharmaceutical, Cholesgen Pharmaceutical, and ETERN Therapeutics within the Drug Discovery industry.

  • What has Wuxi AstraZeneca CICC Venture Capital Partnership invested in recently?

    Wuxi AstraZeneca CICC Venture Capital Partnership's latest investment was on 03-Mar-2025 in Danatlas Pharmaceutical, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »